検索結果

研究開発の取り組み | 千寿製薬株式会社

D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senj...

ctive symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 Clinical Trial*2) successfully met the primary endpoint b...

ctive symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 clinical trial*2 ) successfully met the primary endpoint ...

ctive symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 Clinical Trial*2) successfully met the primary endpoint b...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

ble supply of products which prioritize efficacy and safety to the utmost. When conducting clinical trials, we shall obtain the cooperation of medical establishments and be fully mindful of respecting...